Latest News
From the Journals
Depressed OA patients get far-reaching benefits from Internet-delivered CBT
The benefits of the 10-week program extended beyond depression to improving pain, stiffness, physical functioning, and self-efficacy.
Conference Coverage
Knee injuries in youth sports bring double whammy
Just 3-10 years after sustaining a knee injury while participating in youth sports, 29% of young people already have MRI evidence of knee...
Conference Coverage
Smartphone apps may aid home rheumatoid arthritis monitoring
BIRMINGHAM, ENGLAND – Smartphone apps in development for patients with rheumatoid arthritis are designed to monitor the activity of both the...
From the Journals
Value-based care didn’t trigger spikes in patient dismissals
The transition to value-based care didn’t lead doctors to dismiss patients who could adversely affect their reimbursement.
From the Journals
One-third of drug postmarket studies go unpublished
Why are postmarket studies with relevant findings nowhere to be found?
Conference Coverage
Ankylosing spondylitis disease severity worsened by smoking
BIRMINGHAM, ENGLAND – Smoking at any level appears to worsen disease activity.
Conference Coverage
SLE linked to subsequent risk of malignant melanoma
PORTLAND, ORE. – An analysis of electronic medical records has identified another malignancy associated with systemic lupus erythematosus.
Conference Coverage
For vertebral osteomyelitis, early switch to oral antibiotics is feasible
VIENNA – Many patients with pyogenic vertebral osteomyelitis may have an alternative to IV antibiotics during their treatment course.
Feature
Do you have to MIPS in 2017? CMS has a tool for that
A Web tool from CMS allows physicians to quickly know if they must participate in the Merit-based Incentive Payment System this year.
Law & Medicine
Determining patients’ decisional capacity
When do patients no longer have the medical capacity to make their own health care decisions, and when can surrogates make those decisions for...
Conference Coverage
Dalbavancin proves highly effective in osteomyelitis
VIENNA – Preliminary results of a phase II trial show that the long-acting lipoglycopeptide antibiotic dalbavancin cleared infection in 100% of...